Project Grant R03AA031535

Award Date 9/20/24
Completion Date 8/31/26
Dollars Obligated $77K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
South Orange, NJ 07079, USA
Similar Awards
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) provides $224,250 to Northeast Ohio Medical University (Neomed) to explore the role of Guanylate-Binding Protein 7 (GBP7) in regulating the activation of hematopoietic stem/progenitor cells (HSPCs) and how alcohol impairs this process during the granulopoietic response to septic infection. The research aims to: 1) examine if alcohol suppresses the upregulation of GBP7...
This Project Grant award of $131,654.00 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) aims to develop a Lactobacillus-vectored alkaline phosphatase (AP) to mitigate alcohol-induced leaky gut and reduce lipopolysaccharide (LPS) endotoxin levels in the gut. The project, awarded to Biomedit LLC, has two key objectives: 1) generating engineered live biotherapeutics (ELBPs) that can deliver functional AP, and 2) evaluating the...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support the development and testing of a novel in vivo model called CHIMERA-BONCAT. This model will enable comprehensive, unbiased, and cell-type-specific characterization of the human microglial response to alcohol exposure. The $214,385 award, with a period of performance from August 2024 to July 2026, will fund research...
This federal Project Grant award of $380,863 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), supports research on the role of specific hepatic stellate cell subsets in the progression of alcohol-associated hepatitis (AH). The project aims to determine how the genes CYP1B1, PRRX1, and NR4A2 regulate the development and function of a novel FBLN2+ activated hepatic stellate cell (AHSC) subset in AH. Planned activities include...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund research at the University of Nebraska Medical Center (UNMC) to investigate the mechanisms by which superoxide dismutase 1 (SOD1) protects against alcohol-induced liver and adipose tissue damage. The $374,081 award will support studies to define the interplay among SOD1, adenosine monophosphate-activated protein kinase (AMPK), and...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to examine the role of non-parenchymal cells (NPCs) in driving the key features of Alcohol Associated Hepatitis (AAH) in a fully humanized mouse liver model. The $688,199 award to Yale University will fund research over a 5-year period from June 1, 2025 to February 28, 2030. The research aims to elucidate the NPC-derived...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $537,587 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The University of Texas Southwestern Medical Center to conduct research on the metabolic consequences of liver inflammation on alcohol consumption and alcohol-associated liver disease (ALD). The key objectives are to identify the mechanisms by which the transcription factor IRF3 suppresses the expression and secretion of the metabolic regulator...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $1,547,718 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) from September 1, 2024 to May 31, 2029. The project will investigate the role of KDM5 demethylases in regulating cell-cell communication in the development and resolution of alcohol-associated liver disease. Specifically, the research aims to determine how KDM5B and KDM5C...
This $499,987 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund the development of a High Throughput Alcohol Screening Platform (HT-ASP) that incorporates cortical organoids. The project aims to create an automated platform to mature, maintain, and assay over 100 organoids in culture, providing a robust and genetically diverse system for screening potential alcohol use disorder therapeutics. The...

INVESTIGATION OF COLD PLASMA FOR HEALING ALCOHOL-INDUCED TISSUE INJURY - ABSTRACT: BINGE DRINKING OF ALCOHOL BEVERAGES HINDERS TISSUE REPAIR AND AMPLIFIES THE SUSCEPTIBILITY TO INFECTION. THE PREVALENCE AS WELL AS THE RISKS ASSOCIATED WITH BINGE DRINKING POSES A SIGNIFICANT CONCERN IN THE UNITED STATES. BINGE DRINKING IMPAIRS THE THREE KEY PHASES OF WOUND HEALING: INFLAMMATION, PROLIFERATION, AND REMODELING. SPECIFICALLY, DURING THE INFLAMMATION PHASE, BINGE DRINKING DIMINISHES THE FUNCTION OF PRO-INFLAMMATORY CYTOKINES, NEUTROPHILS, AND MACROPHAGES, THUS COMPROMISING THE INNATE IMMUNE SYSTEM'S ABILITY TO COMBAT PATHOGENS. THE EFFICACY OF CURRENT WOUND HEALING METHODS IS CONSTRAINED BY THE VULNERABILITY TO WOUND INFECTION WHICH IS EXACERBATED BY CONCURRENT BINGE DRINKING. COLD PLASMA (CP) HAS RECENTLY GAINED SUBSTANTIAL ATTENTION IN CLINICAL PRACTICE DUE TO ITS REGENERATIVE PROPERTIES AND ITS ABILITY TO PREVENT INFECTION. PREVIOUS STUDIES HAVE SHOWN THAT CP TREATMENT IS INVOLVED IN THE WOUND HEALING MEDIATED BY THE NRF2 PATHWAY AND WNT/BCATENIN SIGNALING PATHWAY. TAKEN THESE SOLID PREMISES TOGETHER, WE HYPOTHESIZE THAT CP WILL IMPROVE IMPAIRED WOUND HEALING AND MITIGATE THE INCREASED VULNERABILITY TO INFECTION CAUSED BY BINGE DRINKING. TO SUBSTANTIATE THESE HYPOTHESES, WE HAVE PROPOSED TWO FOLLOWING SPECIFIC AIMS USING F344 RAT MODEL AND HUMAN SKIN ORGANOID MODEL, RESPECTIVELY. AIM 1 IS TO CHARACTERIZE WOUND HEALING PROPERTIES OF CP IN F344 RATS FOLLOWING BINGE EXPOSURE TO ALCOHOL. THIS AIM IS TO EXAMINE WOUND CLOSURE PROPERTIES OF CP AND TO REVEAL MOLECULAR MECHANISMS UNDERLYING CP MODULATION OF WOUND HEALING IN BINGE ETOH INTOXICATED F344 RATS. AIM 2 IS TO GENERATE AN IN-VITRO WOUND HEALING MODEL USING HIPSC DERIVED SKIN ORGANOIDS AND TO INVESTIGATE THE POTENTIAL WOUND HEALING PROPERTIES OF CP IN THESE SKIN ORGANOIDS GIVEN BINGE LEVEL OF ETOH. THIS AIM REPRESENTS THE TRANSLATIONAL ASPECT OF OUR STUDIES. WE FIRST WILL DEVELOP AND CHARACTERIZE 3D SKIN ORGANOIDS USING HUMAN INDUCED PLURIPOTENT STEM CELLS (HIPSC) AND THEN IDENTIFY THE POTENTIAL WOUND HEALING PROPERTIES OF CP IN ALCOHOL-TREATED HUMAN SKIN ORGANOIDS. IN ADDITION, WE WILL STUDY MOLECULAR MECHANISMS AND SIGNAL PATHWAYS UNDERLYING CP MODULATION OF WOUND HEALING IN ALCOHOL TREATED SKIN ORGANOIDS USING BOTH IMMUNOFLUORESCENCE AND GENE EXPRESSION ANALYSIS. THESE STUDIES ARE HIGHLY SIGNIFICANT BECAUSE 1) WE ARE TO DEMONSTRATE THE MEDICAL USE OF CP IN WOUND HEALING ASSOCIATED WITH ETOH INTOXICATION, AND 2) WE ARE TO ADDRESS THE TRANSLATIONAL VALUE OF THE PROPOSED STUDIES USING F344 RAT MODEL AND HUMAN CULTURE OF SKIN ORGANOIDS. SUCCESSFUL COMPLETION OF THIS SMALL R03 GRANT AWARD WILL PROVIDE VALUABLE THERAPEUTIC CLUES IN CP MODULATION OF THE WOUND HEALING DURING ETOH INTOXICATION. THE STUDY OUTCOMES SHALL SHIFT THE PARADIGMS REGARDING THE INTERPLAY BETWEEN WOUND HEALING PROPERTIES OF CP AND ALCOHOL- INDUCED IMPAIRMENT OF WOUND HEALING, EVENTUALLY LEADING TO CLINICAL APPLICATION OF CP IN WOUND HEALING DURING ETOH INTOXICATION. WE EXPECT A FULL R01 PROJECT TO BE DEVELOPED IN CONCLUSION OF THIS SMALL R03 PROJECT.

Posted 9/17/24